Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Kinel, D."'
Autor:
Purks JL; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Arbatti L; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Hosamath A; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Amara AW; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Anderson KE; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Chahine L; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Eberly SW; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Kinel D; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Mantri S; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Mathur S; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Oakes D; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Standaert DG; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Weintraub D; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Shoulson I; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada., Marras C; Department of Neurology (JLP, DK, IS), University of Rochester, NY; Grey Matter Technologies (LA, AH, IS), a wholly owned subsidiary of Modality.ai, San Francisco, CA; Department of Neurology (AWA), University of Colorado Anschutz Medical Campus, Aurora; Departments of Psychiatry and Neurology (KEA), Georgetown University, Washington, DC; Department of Neurology (LC), University of Pittsburgh, PA; Department of Biostatistics and Computational Biology (SWE, DO), University of Rochester, NY; Department of Neurology (Sneha Mantri), Duke University, Durham, NC; PD Avengers (Soania Mathur), Toronto, Ontario, Canada; Department of Neurology (DGS), University of Alabama at Birmingham; Departments of Psychiatry and Neurology (DW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; and Edmond J Safra Program in Parkinson's Disease (CM), University Health Network, University of Toronto, Ontario, Canada.
Publikováno v:
Neurology. Clinical practice [Neurol Clin Pract] 2024 Oct; Vol. 14 (5), pp. e200334. Date of Electronic Publication: 2024 Jul 02.
Autor:
Dorsey, E.R., Zafar, M., Lettenberger, S.E., Pawlik, M.E., Kinel, D., Frissen, M.N., Schneider, R.B., Kieburtz, K., Tanner, C.M., Miranda, B.R. De, Goldman, S.M., Bloem, B.R.
Publikováno v:
Journal of Parkinson's Disease, 13, 2, pp. 203-218
Journal of Parkinson's Disease, 13, 203-218
Journal of Parkinson's Disease, 13, 203-218
Contains fulltext : 291452.pdf (Publisher’s version ) (Open Access) The etiologies of Parkinson's disease (PD) remain unclear. Some, such as certain genetic mutations and head trauma, are widely known or easily identified. However, these causes or
Autor:
Weintraub D; Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Marras C; Edmond J. Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada., Amara A; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Anderson KE; Departments of Psychiatry and Neurology, Georgetown University, Washington, DC, USA., Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA., Hosamath A; Grey Matter Technologies, a Wholly Owned Subsidiary of modality.ai, San Francisco, California, USA., Kinel D; Center for Health + Technology, University of Rochester Medical Center, Rochester, New York, USA., Mantri S; Department of Neurology, Duke University, Durham, North Carolina, USA., Mathur S; PD Avengers, Toronto, Ontario, Canada., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA., Purks JL; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Shoulson I; Grey Matter Technologies, a Wholly Owned Subsidiary of modality.ai, San Francisco, California, USA.; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., Arbatti L; Grey Matter Technologies, a Wholly Owned Subsidiary of modality.ai, San Francisco, California, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Apr; Vol. 39 (4), pp. 706-714. Date of Electronic Publication: 2024 Feb 06.
Autor:
Dorsey ER; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Kinel D; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Pawlik ME; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Zafar M; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Lettenberger SE; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Coffey M; Donald and Barbara Zucker School of Medicine, Uniondale, New York, USA., Auinger P; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Hylton KL; Kevin Hylton Environmental Services, Inc., Rochester, New York, USA., Shaw CW; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA., Adams JL; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Barbano R; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., Braun MK; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., Schwarz HB; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA., Lawrence BP; Department of Environmental Medicine, University of Rochester Medical Center, Rochester, New York, USA., Kieburtz K; Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.; Center for Health & Technology, University of Rochester Medical Center, Rochester, New York, USA., Tanner CM; Department of Neurology, UCSF Health, San Francisco, California, USA., de Miranda BR; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Goldman SM; Division of Occupational, Environmental, and Climate Medicine, University of California San Francisco, San Francisco, California, USA.
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Mar; Vol. 39 (3), pp. 606-613. Date of Electronic Publication: 2024 Feb 23.
Autor:
Mantri S; Department of Neurology, Duke University, Durham, NC, USA., Purks JL; Department of Neurology, University of Rochester, Rochester, NY, USA., Kinel D; Department of Neurology, Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA., Arbatti L; Grey Matter Technologies, A Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA., Hosamath A; Grey Matter Technologies, A Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA., Allen A; Department of Neurology, Duke University, Durham, NC, USA., Amara A; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Anderson K; Department of Psychiatry and Department of Neurology, Georgetown University, Washington, DC, USA., Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Mathur S; PD Avengers, Toronto, Canada., Standaert D; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Weintraub D; Departments of Psychiatry and Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shoulson I; Department of Neurology, University of Rochester, Rochester, NY, USA.; Grey Matter Technologies, A Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA., Marras C; Edmond J. Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Canada.
Publikováno v:
Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (4), pp. 865-872.
Autor:
Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, the United States of America., Arbatti L; Grey Matter Technologies, a wholly owned subsidiary of Modality.ai, San Francisco, CA, the United States of America., Hosamath A; Grey Matter Technologies, a wholly owned subsidiary of Modality.ai, San Francisco, CA, the United States of America., Amara A; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, the United States of America., Anderson KE; Departments of Psychiatry and Neurology, Georgetown University, Washington, DC, the United States of America., Purks J; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, the United States of America.; Department of Neurology, University of Rochester Medical Center, Rochester, NY, the United States of America., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, the United States of America., Kinel D; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, the United States of America., Mantri S; Department of Neurology, Duke University, Durham, NC, the United States of America., Mathur S; PD Avengers, Toronto, Canada., Oakes D; Department of Neurology, University of Rochester Medical Center, Rochester, NY, the United States of America., Standaert DG; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, the United States of America., Weintraub D; Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, the United States of America., Shoulson I; Grey Matter Technologies, a wholly owned subsidiary of Modality.ai, San Francisco, CA, the United States of America.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, the United States of America., Marras C; Edmond J Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Canada.
Publikováno v:
Clinical parkinsonism & related disorders [Clin Park Relat Disord] 2023 Nov 07; Vol. 9, pp. 100229. Date of Electronic Publication: 2023 Nov 07 (Print Publication: 2023).
Autor:
Marras C; Edmond J Safra Program in Parkinson's Disease, University Health Network, University of Toronto, Toronto, Canada., Arbatti L; Grey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA., Hosamath A; Grey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA., Amara A; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Anderson KE; Departments of Psychiatry and Neurology, Georgetown University, Washington DC, USA., Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Kinel D; Department of Neurology, University of Rochester, Rochester NY, USA., Mantri S; Department of Neurology, Duke University, Durham, NC, USA., Mathur S; PD Avengers, Toronto, Canada., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Purks JL; Department of Neurology, University of Rochester, Rochester NY, USA., Standaert DG; PD Avengers, Toronto, Canada., Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California - San Francisco, San Francisco, CA, USA., Weintraub D; Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Shoulson I; Grey Matter Technologies, a Wholly Owned Subsidiary of Modality.ai, San Francisco, CA, USA.; Department of Neurology, University of Rochester, Rochester NY, USA.
Publikováno v:
Journal of Parkinson's disease [J Parkinsons Dis] 2023; Vol. 13 (5), pp. 757-767.
Autor:
Jensen-Roberts S; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Myers TL; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Auinger P; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Cannon P; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Rowbotham HM; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Coker D; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Chanoff E; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Soto J; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Pawlik M; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Amodeo K; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Sharma S; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Valdovinos B; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Wilson R; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Sarkar A; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., McDermott MP; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Alcalay RN; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Biglan K; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Kinel D; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Tanner C; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Winter-Evans R; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Augustine EF; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Holloway RG; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Dorsey ER; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD., Schneider RB; Center for Health + Technology (S.J.-R., T.L.M., P.A., J.S., M.P., S.S., R.W., A.S., M.P.M., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; Department of Brain and Psychological Sciences (T.L.M.), Boston University, MA; Department of Neurology (P.A., B.V., M.P.M., K.B., D.K., E.F.A., R.G.H., E.R.D., R.B.S.), University of Rochester Medical Center, NY; 23andMe, Inc. (P.C., H.M.R., D.C., E.C.), Sunnyvale, CA; Department of Neurology (K.A.), Westchester Medical Center, Poughkeepsie, NY; USA Department of Biostatistics and Computational Biology (M.P.M.), University of Rochester Medical Center, NY; Department of Neurology (R.N.A.), Columbia University, New York; Eli Lilly and Company (K.B.), Indianapolis, IN; Weill Institute for Neurosciences (C.T.), University of California, San Francisco; Valley Oaks Health (R.W.-E.), Lafayette, IN; and Department of Neurology and Neurogenetics (E.F.A.), Kennedy Krieger Institute, Baltimore, MD.
Publikováno v:
Neurology. Genetics [Neurol Genet] 2022 Aug 11; Vol. 8 (5), pp. e200008. Date of Electronic Publication: 2022 Aug 11 (Print Publication: 2022).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.